Cargando…

Smoking Cessation Considerations for People with Multiple Sclerosis

BACKGROUND: Comprehensive care of people with multiple sclerosis integrates disease modifying therapy, symptom management and minimization of risk factors for disease progression. Cigarette smoking is a modifiable risk factor associated with development and progression of disease and increased disab...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooker, Christa, Goldman, Myla D., Tingen, S. Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051923/
https://www.ncbi.nlm.nih.gov/pubmed/34007614
http://dx.doi.org/10.24926/iip.v11i2.3210
_version_ 1783679829204271104
author Brooker, Christa
Goldman, Myla D.
Tingen, S. Ross
author_facet Brooker, Christa
Goldman, Myla D.
Tingen, S. Ross
author_sort Brooker, Christa
collection PubMed
description BACKGROUND: Comprehensive care of people with multiple sclerosis integrates disease modifying therapy, symptom management and minimization of risk factors for disease progression. Cigarette smoking is a modifiable risk factor associated with development and progression of disease and increased disability. However, little is known about specific factors that affect smoking cessation in patients with multiple sclerosis or how to integrate smoking cessation into specialized multiple sclerosis care. METHODS: Twenty-nine active smokers with multiple sclerosis were surveyed at the James Q. Miller Multiple Sclerosis clinic at the University of Virginia Health. Demographics, smoking history, multiple sclerosis history, interest in quitting, barriers to quitting and cessation modalities of interest were collected, specifically interest in working with a clinical pharmacist for cessation. RESULTS: Seventy-six percent of individuals believed that there was no relationship between smoking and MS diagnosis and 52% were unaware of any relationship between smoking and disease progression. Less than half of patients (41%) reported receiving counseling from a primary care physician or neurologist about the importance of smoking cessation. Common barriers to quitting included enjoyment of smoking (76%) and cravings (55%). Seventy-six percent of patients expressed interest in utilizing pharmacotherapy and 37% were interested in working closely with a clinical pharmacist. CONCLUSIONS: It is critical that providers caring for patients with multiple sclerosis assess smoking status and educate smokers about the relationship between smoking and disease progression. Efforts should be made to better understand patient-specific barriers to quitting and preferred methods of treatment, including pharmacotherapy and behavioral therapy. A multidisciplinary approach to smoking cessation that includes a clinical pharmacist may aid in the development of individualized care plans with frequent monitoring to improve patient success.
format Online
Article
Text
id pubmed-8051923
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-80519232021-05-17 Smoking Cessation Considerations for People with Multiple Sclerosis Brooker, Christa Goldman, Myla D. Tingen, S. Ross Innov Pharm Case Study BACKGROUND: Comprehensive care of people with multiple sclerosis integrates disease modifying therapy, symptom management and minimization of risk factors for disease progression. Cigarette smoking is a modifiable risk factor associated with development and progression of disease and increased disability. However, little is known about specific factors that affect smoking cessation in patients with multiple sclerosis or how to integrate smoking cessation into specialized multiple sclerosis care. METHODS: Twenty-nine active smokers with multiple sclerosis were surveyed at the James Q. Miller Multiple Sclerosis clinic at the University of Virginia Health. Demographics, smoking history, multiple sclerosis history, interest in quitting, barriers to quitting and cessation modalities of interest were collected, specifically interest in working with a clinical pharmacist for cessation. RESULTS: Seventy-six percent of individuals believed that there was no relationship between smoking and MS diagnosis and 52% were unaware of any relationship between smoking and disease progression. Less than half of patients (41%) reported receiving counseling from a primary care physician or neurologist about the importance of smoking cessation. Common barriers to quitting included enjoyment of smoking (76%) and cravings (55%). Seventy-six percent of patients expressed interest in utilizing pharmacotherapy and 37% were interested in working closely with a clinical pharmacist. CONCLUSIONS: It is critical that providers caring for patients with multiple sclerosis assess smoking status and educate smokers about the relationship between smoking and disease progression. Efforts should be made to better understand patient-specific barriers to quitting and preferred methods of treatment, including pharmacotherapy and behavioral therapy. A multidisciplinary approach to smoking cessation that includes a clinical pharmacist may aid in the development of individualized care plans with frequent monitoring to improve patient success. University of Minnesota Libraries Publishing 2020-04-30 /pmc/articles/PMC8051923/ /pubmed/34007614 http://dx.doi.org/10.24926/iip.v11i2.3210 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Study
Brooker, Christa
Goldman, Myla D.
Tingen, S. Ross
Smoking Cessation Considerations for People with Multiple Sclerosis
title Smoking Cessation Considerations for People with Multiple Sclerosis
title_full Smoking Cessation Considerations for People with Multiple Sclerosis
title_fullStr Smoking Cessation Considerations for People with Multiple Sclerosis
title_full_unstemmed Smoking Cessation Considerations for People with Multiple Sclerosis
title_short Smoking Cessation Considerations for People with Multiple Sclerosis
title_sort smoking cessation considerations for people with multiple sclerosis
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051923/
https://www.ncbi.nlm.nih.gov/pubmed/34007614
http://dx.doi.org/10.24926/iip.v11i2.3210
work_keys_str_mv AT brookerchrista smokingcessationconsiderationsforpeoplewithmultiplesclerosis
AT goldmanmylad smokingcessationconsiderationsforpeoplewithmultiplesclerosis
AT tingensross smokingcessationconsiderationsforpeoplewithmultiplesclerosis